Anales de Pediatría (English Edition)

ISSN: 2341-2879

The Spanish Pediatric Association (Asociación Española de Pediatría, AEP) has as one of its main objectives the dissemination of rigorous and up-to-date scientific information on the various areas of pediatrics. Annals of Pediatrics is an open access journal that serves as the Association's Scientific Expression Organ and constitutes the vehicle through which members communicate. Annals of Pediatrics publishes, in English and Spanish, original research papers on pediatrics, as well as review articles prepared by experts in each specialty, and guidelines or positioning documents prepared by the different Societies/Specialized Sections integrated into the Spanish Pediatric Association. The journal, a reference for Spanish-speaking pediatrics, is indexed in the most important international databases: Index Medicus/Medline IBECS, IME, SCOPUS, Science Citation Index Expanded, Journal Citations Report, Embase/Excerpta Medica, Directory of Open Access Journals (DOAJ).

Indexed in:

Index Medicus/Medline IBECS, IME, SCOPUS, Science Citation Index Expanded, Journal Citations Report, Embase/Excerpta Medica, Directory of Open Access Journals (DOAJ)

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

2.1

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.274

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.572

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Original Article

A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for paediatric Crohn's disease

Efectividad y seguridad en nuestro entorno del adalimumab como tratamiento anti-TNF de primera linea en niños con enfermedad de Crohn

Víctor Manuel Navas-Lópeza,b,

Corresponding author

victor.navas@gmail.com

Corresponding author.

, Gemma Pujol-Muncunillc, Enrique Llerenac, María Navalón Rubiod, David Gil-Ortegad, Vicente Varea-Calderónc, Carlos Sierra Salinasa,b, Javier Martin-de-Carpic

a Sección de Gastroenterología y Nutrición Infantil, Hospital Materno Infantil, Málaga, Spain

b Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain

c Unidad para el Cuidado Integral de la Enfermedad Inflamatoria Intestinal Pediátrica, Sección de Gastroenterología, Hepatología y Nutrición Pediátrica, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain

d Unidad de Gastroenterología y Nutrición Pediátrica, Hospital Virgen de la Arrixaca, Murcia, Spain

Read

8118

Times
was read the article

2908

Total PDF

5210

Total HTML

Share statistics

Article information

ISSN: 23412879
Original language: English

DOI:10.1016/j.anpede.2017.03.001

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 April	34	24	58
2024 March	63	34	97
2024 February	62	26	88
2024 January	52	25	77
2023 December	73	17	90
2023 November	60	20	80
2023 October	54	27	81
2023 September	31	23	54
2023 August	36	26	62
2023 July	70	26	96
2023 June	32	26	58
2023 May	66	33	99
2023 April	50	29	79
2023 March	68	23	91
2023 February	40	24	64
2023 January	34	31	65
2022 December	75	31	106
2022 November	88	55	143
2022 October	79	64	143
2022 September	42	46	88
2022 August	69	62	131
2022 July	65	57	122
2022 June	73	63	136
2022 May	84	43	127
2022 April	144	66	210
2022 March	174	72	246
2022 February	155	57	212
2022 January	136	57	193
2021 December	71	56	127
2021 November	91	59	150
2021 October	74	108	182
2021 September	45	48	93
2021 August	43	64	107
2021 July	41	48	89
2021 June	43	49	92
2021 May	82	60	142
2021 April	320	139	459
2021 March	81	75	156
2021 February	50	24	74
2021 January	43	32	75
2020 December	59	20	79
2020 November	48	27	75
2020 October	30	23	53
2020 September	42	27	69
2020 August	42	25	67
2020 July	50	24	74
2020 June	47	12	59
2020 May	89	35	124
2020 April	32	11	43
2020 March	99	40	139
2020 February	212	30	242
2020 January	114	17	131
2019 December	120	25	145
2019 November	46	15	61
2019 October	51	10	61
2019 September	37	22	59
2019 August	77	18	95
2019 July	46	40	86
2019 June	39	30	69
2019 May	63	20	83
2019 April	59	44	103
2019 March	56	26	82
2019 February	64	33	97
2019 January	86	32	118
2018 December	77	38	115
2018 November	154	33	187
2018 October	191	32	223
2018 September	79	26	105
2018 August	4	0	4
2018 July	6	0	6
2018 June	5	0	5
2018 May	14	0	14
2018 April	39	0	39
2018 March	40	0	40
2018 January	0	12	12
2017 December	0	19	19
2017 November	0	23	23
2017 October	0	23	23
2017 September	0	20	20
2017 August	0	18	18
2017 July	0	15	15
2017 June	0	31	31
2017 May	0	49	49
2017 April	0	114	114

Show all

Follow this link to access the full text of the article

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter